相关实验视频

Updated: Jul 17, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

[重新讨论乳腺癌内分泌治疗的热点问题]

Y Yuan¹, Z F Jiang¹

¹Senior Department of Oncology, the Fifth Medical Centre of Chinese People's Liberation Army (PLA) General Hospital, Beijing 100071, China.

Zhonghua yi xue za zhi

|September 7, 2023

概括

最近内分泌疗法和指导方针的进步改变了乳腺癌的治疗方法. 本综述解决了新辅助内分泌疗法和CDK4/6抑制剂用于晚期乳腺癌的关键问题.

科学领域:

在瘤学瘤学.
内分泌学在内分泌学.
临床研究临床研究

背景情况:

在过去的十年中,内分泌疗法的大规模临床研究已经发展.
更新的临床指导方针对乳腺癌治疗策略产生了重大影响.
尽管取得了进展,但在内分泌治疗的临床应用中,仍有许多未解决的问题.

研究的目的:

讨论关于乳腺癌内分泌治疗的当前证据和临床经验.
提供关于未解决问题的见解和内分泌治疗的未来方向.
为乳腺癌管理内分泌治疗的各个方面提供专家意见.

主要方法:

审查最近的大规模临床研究数据.
分析最新的临床实践指南.
专家临床经验和新证据的综合.

主要成果:

新辅助性内分泌治疗策略及其有效性.
在辅助治疗中CDK4/6抑制剂的作用和应用.
了解和管理内分泌敏感性和抵抗.
转移性乳腺癌的第一线治疗方法.
在使用CDK4/6抑制剂后进展后的治疗选择.
乳腺癌患者内脏危机的管理策略.

结论:

内分泌疗法仍然是乳腺癌管理的基石,正在不断演变.
解决耐药性和优化治疗顺序对于改善治疗结果至关重要.
考虑到内分泌敏感性和耐药性的个性化方法对于有效的治疗至关重要.

更多相关视频

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...